Mechanistic studies demonstrated that, in addition to potent direct cell lysis, OncoVEXmGM-CSF induces immunogenic cell death and potent anti-tumor immunity, with additional demonstration that adoptive transfer of cluster of differentiation 8 (CD8)+ T cells from cured mice confers protection against tumor challenge [31]. The gene discussed is CD8A; the disease is neoplasm.